Search Tag: Joe Kiani
2020 31 Aug
Masimo today announced that O3® Regional Oximetry has received FDA clearance for expanded use in monitoring somatic tissue oxygenation saturation in all patient populations and monitoring relative changes in hemoglobin, oxyhemoglobin, and deoxyhemoglobin in adult brains. With this FDA clearance, O3 is now indicated for use in both cerebral and somatic...Read more
2020 27 Jul
The Radius Tº™ Wearable Temperature Sensor Automates Remote Monitoring of Patient Temperature Status Masimo today announced a significant expansion to the Masimo SafetyNet™ platform with the introduction of Radius Tº™, a wearable, wireless sensor that provides continuous body temperature measurements. By augmenting the already powerful Masimo...Read more
2020 14 Jul
UniView: 60 Uses the Power of the Masimo Hospital Automation™ Platform to Improve Clinical Workflows and Hand-off Communication Masimo today announced its latest automation and connectivity solution, UniView: 60™. UniView: 60 uses the Masimo Hospital Automation™ platform to aggregate and display pertinent patient information on a digital display...Read more
2020 29 Jun
Drug-free Neurostimulation Device Reduces the Symptoms of Opioid Withdrawal Masimo today announced Bridge™, an opioid withdrawal solution that uses neuromodulation to aid in the reduction of symptoms associated with opioid withdrawal. Bridge, which has been granted an FDA De Novo classification, is the first evidence-based, drug-free, non-surgical...Read more
2020 25 Jun
Wearable, Wireless Patient Orientation, Activity, and Respiration Sensor Helps Clinicians Monitor Patient Position and Respiration Rate Masimo announced today that Centroid™, a wearable, wireless patient orientation, activity, and respiration rate sensor, has received FDA clearance. Centroid helps clinicians monitor patient position to avoid...Read more
2020 19 Jun
Suite of Integrated Turnkey Tools Helps Businesses, Governments, and Schools Reopen and Stay Open Responsibly During COVID-19 IRVINE, Calif.--( BUSINESS WIRE )-- Masimo (NASDAQ: MASI) today announced Masimo SafetyNet-Open™, designed to help businesses, governments, and schools more responsibly manage employee and student health and safety...Read more
2020 27 May
Masimo and Royal Philips , both global leaders in patient monitoring, announced today that they have reinforced their partnership, whereby Philips will integrate additional Masimo measurement technologies into select IntelliVue® MX-series multi-parameter monitors, to help clinicians assess cerebral oximetry and ventilation status. Core Masimo...Read more
2019 19 Dec
Masimo and Dräger announced today that they have expanded their partnership, whereby Dräger will integrate additional Masimo measurement technologies into Dräger’s family of multi-parameter patient monitors, to help clinicians assess brain function, oxygenation, and ventilation status. This press release features multimedia. View the full release...Read more
2018 06 Mar
Today at the 2018 HIMSS Annual Conference, Masimo announced the release of Replica™, an application for smart phones and tablets that works in conjunction with Masimo Patient SafetyNet™*, a supplemental remote monitoring and clinician notification system. Replica allows clinicians to view continuous monitoring data for multiple patients, as well...Read more
2017 02 Oct
Masimo rainbow Acoustic Monitoring® RAS-45 Acoustic Respiration Sensor Masimo has announced the full market release of RAS-45, an adhesive adult and pediatric acoustic respiration sensor for rainbow Acoustic Monitoring® (RAM™). RAS-45 offers the same performance as the currently available RAS-125c sensor but in a smaller size, with more flexible...Read more